PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. FDA for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals.
The details can be read here.
No comments:
Post a Comment